Paul Sekhri

Paul J. Sekhri is a seasoned life sciences executive with over 35 years of leadership experience across global pharmaceutical, biotechnology, and venture-backed companies. He currently serves as Chairman, President, and CEO of vTv Therapeutics and is joining Nodenza’s Advisory Board, where he will provide strategic and commercial guidance on healthcare, biotech, and medtech investments.

Previously, Paul held senior leadership roles at Sanofi, Teva, Novartis, ARIAD Pharmaceuticals, and TPG Biotech, where he led global business development, M&A, innovation, and venture investing initiatives.

In addition to his life sciences work, he is actively involved in the arts, serving in leadership and advisory roles with prominent cultural institutions including Young Concert Artists and the New York Philharmonic.